BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 19268499)

  • 1. Allopregnanolone has no effect on startle response and prepulse inhibition of startle response in patients with premenstrual dysphoric disorder or healthy controls.
    Kask K; Bäckström T; Lundgren P; Sundström Poromaa I
    Pharmacol Biochem Behav; 2009 Jun; 92(4):608-13. PubMed ID: 19268499
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of a low dose of alcohol on allopregnanolone serum concentrations across the menstrual cycle in women with severe premenstrual syndrome and controls.
    Nyberg S; Andersson A; Zingmark E; Wahlström G; Bäckström T; Sundström-Poromaa I
    Psychoneuroendocrinology; 2005 Oct; 30(9):892-901. PubMed ID: 15979810
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Associations of histories of depression and PMDD diagnosis with allopregnanolone concentrations following the oral administration of micronized progesterone.
    Klatzkin RR; Morrow AL; Light KC; Pedersen CA; Girdler SS
    Psychoneuroendocrinology; 2006 Nov; 31(10):1208-19. PubMed ID: 17046166
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Allopregnanolone decrease with symptom improvement during placebo and gonadotropin-releasing hormone agonist treatment in women with severe premenstrual syndrome.
    Nyberg S; Bäckström T; Zingmark E; Purdy RH; Poromaa IS
    Gynecol Endocrinol; 2007 May; 23(5):257-66. PubMed ID: 17558683
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Progesterone metabolite allopregnanolone in women with premenstrual syndrome.
    Rapkin AJ; Morgan M; Goldman L; Brann DW; Simone D; Mahesh VB
    Obstet Gynecol; 1997 Nov; 90(5):709-14. PubMed ID: 9351749
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sex steroid induced negative mood may be explained by the paradoxical effect mediated by GABAA modulators.
    Andréen L; Nyberg S; Turkmen S; van Wingen G; Fernández G; Bäckström T
    Psychoneuroendocrinology; 2009 Sep; 34(8):1121-32. PubMed ID: 19272715
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patients with premenstrual dysphoric disorder have increased startle modulation during anticipation in the late luteal phase period in comparison to control subjects.
    Bannbers E; Kask K; Wikström J; Risbrough V; Poromaa IS
    Psychoneuroendocrinology; 2011 Sep; 36(8):1184-92. PubMed ID: 21435793
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of premenstrual dysphoric disorder with the GABA
    Bixo M; Ekberg K; Poromaa IS; Hirschberg AL; Jonasson AF; Andréen L; Timby E; Wulff M; Ehrenborg A; Bäckström T
    Psychoneuroendocrinology; 2017 Jun; 80():46-55. PubMed ID: 28319848
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of GABA active steroids in the female brain with a focus on the premenstrual dysphoric disorder.
    Bixo M; Johansson M; Timby E; Michalski L; Bäckström T
    J Neuroendocrinol; 2018 Feb; 30(2):. PubMed ID: 29072794
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Allopregnanolone and mood disorders.
    Bäckström T; Bixo M; Johansson M; Nyberg S; Ossewaarde L; Ragagnin G; Savic I; Strömberg J; Timby E; van Broekhoven F; van Wingen G
    Prog Neurobiol; 2014 Feb; 113():88-94. PubMed ID: 23978486
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Women with premenstrual dysphoric disorder have altered sensitivity to allopregnanolone over the menstrual cycle compared to controls-a pilot study.
    Timby E; Bäckström T; Nyberg S; Stenlund H; Wihlbäck AN; Bixo M
    Psychopharmacology (Berl); 2016 Jun; 233(11):2109-2117. PubMed ID: 26960697
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patients with premenstrual dysphoric disorder have increased startle response across both cycle phases and lower levels of prepulse inhibition during the late luteal phase of the menstrual cycle.
    Kask K; Gulinello M; Bäckström T; Geyer MA; Sundström-Poromaa I
    Neuropsychopharmacology; 2008 Aug; 33(9):2283-90. PubMed ID: 17940552
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alterations in neonatal neurosteroids affect exploration during adolescence and prepulse inhibition in adulthood.
    Darbra S; Pallarès M
    Psychoneuroendocrinology; 2010 May; 35(4):525-35. PubMed ID: 19775818
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Allopregnanolone serum concentrations and diurnal cortisol secretion in women with premenstrual dysphoric disorder.
    Segebladh B; Bannbers E; Moby L; Nyberg S; Bixo M; Bäckström T; Sundström Poromaa I
    Arch Womens Ment Health; 2013 Apr; 16(2):131-7. PubMed ID: 23329007
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential effects of alprazolam on the baseline and fear-potentiated startle reflex in humans: a dose-response study.
    Riba J; Rodríguez-Fornells A; Urbano G; Morte A; Antonijoan R; Barbanoj MJ
    Psychopharmacology (Berl); 2001 Oct; 157(4):358-67. PubMed ID: 11605094
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Allopregnanolone levels and reactivity to mental stress in premenstrual dysphoric disorder.
    Girdler SS; Straneva PA; Light KC; Pedersen CA; Morrow AL
    Biol Psychiatry; 2001 May; 49(9):788-97. PubMed ID: 11331087
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Histories of sexual abuse are associated with differential effects of clonidine on autonomic function in women with premenstrual dysphoric disorder.
    Bunevicius R; Hinderliter AL; Light KC; Leserman J; Pedersen CA; Girdler SS
    Biol Psychol; 2005 Jul; 69(3):281-96. PubMed ID: 15925031
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lower levels of prepulse inhibition of startle response in pregnant women compared to postpartum women.
    Kask K; Bäckström T; Gulinello M; Sundström-Poromaa I
    Psychoneuroendocrinology; 2008 Jan; 33(1):100-7. PubMed ID: 18037247
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 5α-Reductase Inhibition Prevents the Luteal Phase Increase in Plasma Allopregnanolone Levels and Mitigates Symptoms in Women with Premenstrual Dysphoric Disorder.
    Martinez PE; Rubinow DR; Nieman LK; Koziol DE; Morrow AL; Schiller CE; Cintron D; Thompson KD; Khine KK; Schmidt PJ
    Neuropsychopharmacology; 2016 Mar; 41(4):1093-102. PubMed ID: 26272051
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lack of beneficial effects of clonidine in the treatment of premenstrual dysphoric disorder: results of a double-blind, randomized study.
    Bunevicius R; Hinderliter AL; Light KC; Pedersen CA; Girdler SS
    Hum Psychopharmacol; 2005 Jan; 20(1):33-9. PubMed ID: 15536640
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.